Literature DB >> 146486

Nonidentical subunits of human erythrocyte phosphofructokinase.

J Kaur, R B Layzer.   

Abstract

Human erythrocyte and muscle phosphofructokinase (PFK) were purified completely by improved procedures. SDS-acrylamide gel electrophoresis in a discontinuous buffer system revealed two subunits (R and M) of erythrocyte PFK, the slower one (M) corresponding to the single subunit of muscle PFK. The staining intensity ratio R:M of the two bands of erythrocyte PFK was 2:1 or less. This suggests that native erythrocyte PFK contains multiple isoenzymes with different proportions of R and M, some being lost during purification. Nevertheless, isoelectric focusing showed single peaks of erythrocyte PFK (pI 5.0) and muscle PFK (pI 6.6), perhaps because of aggregation of erythrocyte PFK isoenzymes. Erythrocyte PFK from a patient with muscle PFK deficiency had a pI of 4.6 and could not be precipitated by antiserum against muscle PFK, findings compatible with the putative structure R4.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 146486     DOI: 10.1007/bf00484503

Source DB:  PubMed          Journal:  Biochem Genet        ISSN: 0006-2928            Impact factor:   1.890


  15 in total

1.  Phosphofructokinase from human erythrocytes.

Authors:  R B Layzer
Journal:  Methods Enzymol       Date:  1975       Impact factor: 1.600

2.  DISC ELECTROPHORESIS. II. METHOD AND APPLICATION TO HUMAN SERUM PROTEINS.

Authors:  B J DAVIS
Journal:  Ann N Y Acad Sci       Date:  1964-12-28       Impact factor: 5.691

3.  Segregation of membrane components using isoelectric focusing in polyacrylamide gels.

Authors:  D C Merz; R A Good; G W Litman
Journal:  Biochem Biophys Res Commun       Date:  1972-10-06       Impact factor: 3.575

4.  Aggregation of rabbit muscle phosphofructokinase.

Authors:  M J Pavelich; G G Hammes
Journal:  Biochemistry       Date:  1973-03-27       Impact factor: 3.162

5.  The molecular basis of muscle phosphofructokinase deficiency.

Authors:  R B Layzer; J Rasmussen
Journal:  Arch Neurol       Date:  1974-12

6.  Blood cell phosphofructokinase in Down's syndrome.

Authors:  M M Conway; R B Layzer
Journal:  Humangenetik       Date:  1970

7.  A method for immediate visualization of proteins in acrylamide gels and its use for preparation of antibodies to enzymes.

Authors:  B K Hartman; S Udenfriend
Journal:  Anal Biochem       Date:  1969-09       Impact factor: 3.365

8.  Conformational studies on proteins by isoelectric focusing.

Authors:  N Ui
Journal:  Ann N Y Acad Sci       Date:  1973-06-15       Impact factor: 5.691

9.  The reliability of molecular weight determinations by dodecyl sulfate-polyacrylamide gel electrophoresis.

Authors:  K Weber; M Osborn
Journal:  J Biol Chem       Date:  1969-08-25       Impact factor: 5.157

10.  Some properties of the protein forming the outer fibers of cilia.

Authors:  F L Renaud; A J Rowe; I R Gibbons
Journal:  J Cell Biol       Date:  1968-01       Impact factor: 10.539

View more
  5 in total

Review 1.  Advances in hereditary red cell enzyme anomalies.

Authors:  A Kahn; J C Kaplan; J C Dreyfus
Journal:  Hum Genet       Date:  1979       Impact factor: 4.132

Review 2.  A review of animal phosphofructokinase isozymes with an emphasis on their physiological role.

Authors:  G A Dunaway
Journal:  Mol Cell Biochem       Date:  1983       Impact factor: 3.396

3.  Isozymes of human phosphofructokinase: identification and subunit structural characterization of a new system.

Authors:  S Vora; C Seaman; S Durham; S Piomelli
Journal:  Proc Natl Acad Sci U S A       Date:  1980-01       Impact factor: 11.205

4.  Inherited erythrocyte phosphofructokinase deficiency: molecular mechanism.

Authors:  J Etiemble; C Picat; J Siméon; C Blatrix; P Boivin
Journal:  Hum Genet       Date:  1980       Impact factor: 4.132

5.  Analysis of the phosphofructokinase subunits and isoenzymes in human tissues.

Authors:  G A Dunaway; T P Kasten; T Sebo; R Trapp
Journal:  Biochem J       Date:  1988-05-01       Impact factor: 3.857

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.